Patents Assigned to Threshold Pharmaceuticals
  • Anti-cancer therapies
    Patent number: 9205098
    Abstract: Methods for the treatment of cancer are described. In particular, methods for treatment of cancer comprising administration of glufosfamide alone or in combination with another anticancer agent are disclosed.
    Type: Grant
    Filed: October 23, 2012
    Date of Patent: December 8, 2015
    Assignee: Threshold Pharmaceuticals
    Inventor: George Tidmarsh
  • Hypoxia activated drugs of nitrogen mustard alkylators
    Patent number: 8309554
    Abstract: Hypoxia activated drug compounds having a structure of formula (I) are useful in the treatment of cancer and other hyperproliferative diseases.
    Type: Grant
    Filed: May 14, 2009
    Date of Patent: November 13, 2012
    Assignee: Threshold Pharmaceuticals
    Inventors: Jason Lewis, Mark Matteucci, Tao Chen, Hailong Jiao